Cancer clinical trials in the region Auvergne-Rhône-Alpes
342 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Lymphoma
#NCT04077723
#2019-000416-28
B cell lymphoma
None
CD20
CD19
1
2
3 or more
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Hoffmann-La Roche
Phase 1 / Phase 2
Lymphoma
#NCT06495723
#2023-509648-88-00
Escalade et extension de dose
T cell lymphoma
Peripheral T cell lymphoma
None
1
2
3 or more
Chemotherapy
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
Xenothera SAS
Phase 1 / Phase 2
Lymphoma
#NCT04077723
#2019-000416-28
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Indolent transformed lymphoma
CD20
CD19
1
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Hoffmann-La Roche
Phase 1 / Phase 2
Lymphoma
#NCT03075696
#2016-001185-28
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Indolent transformed lymphoma
CD20
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Hoffmann-La Roche
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT04077723
#2019-000416-28
B cell lymphoma
Richter's syndrome
Mantel cell lymphoma
CD20
CD19
1
2
3 or more
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Hoffmann-La Roche
Phase 1 / Phase 2
Breast cancer
#NCT04626635
#2022-501234-37-00
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lymphoma
#NCT05475925
Escalade de dose (partie A) et Extension de dose (partie B) Cohorte B2
T cell lymphoma
Peripheral T cell lymphoma
Cutaneous T-cell lymphoma
Disseminated (stage III and IV)
None
Treated / Controled
2
3 or more
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Dren Bio
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT06923761
#2023-504845-30-00
Module 2 Partie D cancer colorectal pMMR/MSS
Locally Advanced
Metastatic
MSS/pMMR
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Grey Wolf Therapeutics
Phase 1 / Phase 2
Lung cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT06923761
#2023-504845-30-00
Module 2 Cohorte 3 Tumeurs solides avec un TMB médian modéré à élevé
NSCLC (Non-Small Cell Lung Cancer)
Stomach
Oesogastric junction
Esophagus
Invasive bladder cancer
Adenocarcinoma
Squamous cell carcinoma
Urothelial carcinoma
Locally Advanced
Metastatic
1
2
Immunotherapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Grey Wolf Therapeutics
Phase 1 / Phase 2
Liver and bile duct cancer
#NCT06923761
#2023-504845-30-00
Module 2 Cohorte 2 carcinome hépatocellulaire
Hepatocellular carcinoma
Locally Advanced
Metastatic
Unhealthy
A
1
2
Immunotherapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Grey Wolf Therapeutics